<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e> (APLS) is characterized by <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, thromboembolic phenomena and recurrent fetal loss, associated with anti-<z:chebi fb="0" ids="28494">cardiolipin</z:chebi> antibodies (ACA) and/or <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>The syndrome may be primary or may be associated with other conditions such as <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) </plain></SENT>
<SENT sid="2" pm="."><plain>In this study we induced primary APLS following immunization of BALB/c mice with a human monoclonal ACA (H-3) </plain></SENT>
<SENT sid="3" pm="."><plain>Analysis of the cytokine profile of the mice with experimental APLS indicated low production of IL-2, IL-3 and granulocyte-macrophage colony-stimulating factor (GM-CSF) by concanavalin A (Con A)-stimulated splenocytes of H-3 immunized mice </plain></SENT>
<SENT sid="4" pm="."><plain>It seems that the low levels of IL-3 and GM-CSF have a potential role in the fetal loss of the APLS </plain></SENT>
<SENT sid="5" pm="."><plain>Whatever the mechanism of IL-3 and GM-CSF in preventing fetal loss, these results may have therapeutic bearing on the reproductive outcome in women and other species with APLS </plain></SENT>
</text></document>